A detailed history of Real Talk Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Real Talk Capital, LLC holds 1,346 shares of JNJ stock, worth $268,634. This represents 0.25% of its overall portfolio holdings.

Number of Shares
1,346
Previous 1,345 0.07%
Holding current value
$268,634
Previous $223 Million 7.85%
% of portfolio
0.25%
Previous 0.3%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$155.17 - $185.42 $21,878 - $26,144
141 Added 10.48%
1,487 $276 Million
Q3 2025

Nov 13, 2025

BUY
$155.17 - $185.42 $155 - $185
1 Added 0.07%
1,346 $206 Million
Q1 2025

Jun 20, 2025

BUY
$142.06 - $167.7 $191,070 - $225,556
1,345 New
1,345 $223 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $522B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Real Talk Capital, LLC Portfolio

Follow Real Talk Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Real Talk Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Real Talk Capital, LLC with notifications on news.